United States Celiac Disease Market Report 2017

August 2017 | 108 pages | ID: U058EB298B9EN
QYResearch

Abstracts

In this report, the United States Celiac Disease market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Celiac Disease in these regions, from 2012 to 2022 (forecast).

United States Celiac Disease market competition by top manufacturers/players, with Celiac Disease sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• F. Hoffmann-La Roche
• Johnson & Johnson
• Merck
• Pfizer
• ADMA Biologics
• Amgen
• Anthera Pharmaceuticals
• Bayer
• Biogen
• BioLineRx
• Biotest
• Bristol-Myers Squibb
• Celgene
• Takeda Pharmaceutical
• Novartis
• LFB Group
• Kedrion Biopharma

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Distension
• Diarrhea
• Anorexia
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Celiac Disease for each application, including

• First line of treatment
• Second line of treatment

Contents

United States Celiac Disease Market Report 2017

1 CELIAC DISEASE OVERVIEW

1.1 Product Overview and Scope of Celiac Disease
1.2 Classification of Celiac Disease by Product Category
  1.2.1 United States Celiac Disease Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Celiac Disease Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Distension
  1.2.4 Diarrhea
  1.2.5 Anorexia
  1.2.6 Others
1.3 United States Celiac Disease Market by Application/End Users
  1.3.1 United States Celiac Disease Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 First line of treatment
  1.3.3 Second line of treatment
1.4 United States Celiac Disease Market by Region
  1.4.1 United States Celiac Disease Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Celiac Disease Status and Prospect (2012-2022)
  1.4.3 Southwest Celiac Disease Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Celiac Disease Status and Prospect (2012-2022)
  1.4.5 New England Celiac Disease Status and Prospect (2012-2022)
  1.4.6 The South Celiac Disease Status and Prospect (2012-2022)
  1.4.7 The Midwest Celiac Disease Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Celiac Disease (2012-2022)
  1.5.1 United States Celiac Disease Sales and Growth Rate (2012-2022)
  1.5.2 United States Celiac Disease Revenue and Growth Rate (2012-2022)

2 UNITED STATES CELIAC DISEASE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Celiac Disease Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Celiac Disease Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Celiac Disease Average Price by Players/Suppliers (2012-2017)
2.4 United States Celiac Disease Market Competitive Situation and Trends
  2.4.1 United States Celiac Disease Market Concentration Rate
  2.4.2 United States Celiac Disease Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Celiac Disease Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CELIAC DISEASE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Celiac Disease Sales and Market Share by Region (2012-2017)
3.2 United States Celiac Disease Revenue and Market Share by Region (2012-2017)
3.3 United States Celiac Disease Price by Region (2012-2017)

4 UNITED STATES CELIAC DISEASE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Celiac Disease Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Celiac Disease Revenue and Market Share by Type (2012-2017)
4.3 United States Celiac Disease Price by Type (2012-2017)
4.4 United States Celiac Disease Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CELIAC DISEASE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Celiac Disease Sales and Market Share by Application (2012-2017)
5.2 United States Celiac Disease Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CELIAC DISEASE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 F. Hoffmann-La Roche
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Celiac Disease Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 F. Hoffmann-La Roche Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Johnson & Johnson
  6.2.2 Celiac Disease Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Johnson & Johnson Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.2 Celiac Disease Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Celiac Disease Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 ADMA Biologics
  6.5.2 Celiac Disease Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 ADMA Biologics Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Amgen
  6.6.2 Celiac Disease Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Amgen Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Anthera Pharmaceuticals
  6.7.2 Celiac Disease Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Anthera Pharmaceuticals Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bayer
  6.8.2 Celiac Disease Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bayer Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Biogen
  6.9.2 Celiac Disease Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Biogen Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 BioLineRx
  6.10.2 Celiac Disease Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 BioLineRx Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Biotest
6.12 Bristol-Myers Squibb
6.13 Celgene
6.14 Takeda Pharmaceutical
6.15 Novartis
6.16 LFB Group
6.17 Kedrion Biopharma

7 CELIAC DISEASE MANUFACTURING COST ANALYSIS

7.1 Celiac Disease Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Celiac Disease

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Celiac Disease Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Celiac Disease Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CELIAC DISEASE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Celiac Disease Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Celiac Disease Sales Volume Forecast by Type (2017-2022)
11.3 United States Celiac Disease Sales Volume Forecast by Application (2017-2022)
11.4 United States Celiac Disease Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Celiac Disease
Figure United States Celiac Disease Market Size (K Units) by Type (2012-2022)
Figure United States Celiac Disease Sales Volume Market Share by Type (Product Category) in 2016
Figure Distension Product Picture
Figure Diarrhea Product Picture
Figure Anorexia Product Picture
Figure Others Product Picture
Figure United States Celiac Disease Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Celiac Disease by Application in 2016
Figure First line of treatment Examples
Figure Second line of treatment Examples
Figure United States Celiac Disease Market Size (Million USD) by Region (2012-2022)
Figure The West Celiac Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Celiac Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Celiac Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Celiac Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Celiac Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Celiac Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Celiac Disease Sales (K Units) and Growth Rate (2012-2022)
Figure United States Celiac Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Celiac Disease Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Celiac Disease Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Celiac Disease Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Celiac Disease Sales Share by Players/Suppliers
Figure 2017 United States Celiac Disease Sales Share by Players/Suppliers
Figure United States Celiac Disease Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Celiac Disease Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Celiac Disease Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Celiac Disease Revenue Share by Players/Suppliers
Figure 2017 United States Celiac Disease Revenue Share by Players/Suppliers
Table United States Market Celiac Disease Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Celiac Disease Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Celiac Disease Market Share of Top 3 Players/Suppliers
Figure United States Celiac Disease Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Celiac Disease Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Celiac Disease Product Category
Table United States Celiac Disease Sales (K Units) by Region (2012-2017)
Table United States Celiac Disease Sales Share by Region (2012-2017)
Figure United States Celiac Disease Sales Share by Region (2012-2017)
Figure United States Celiac Disease Sales Market Share by Region in 2016
Table United States Celiac Disease Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Celiac Disease Revenue Share by Region (2012-2017)
Figure United States Celiac Disease Revenue Market Share by Region (2012-2017)
Figure United States Celiac Disease Revenue Market Share by Region in 2016
Table United States Celiac Disease Price (USD/Unit) by Region (2012-2017)
Table United States Celiac Disease Sales (K Units) by Type (2012-2017)
Table United States Celiac Disease Sales Share by Type (2012-2017)
Figure United States Celiac Disease Sales Share by Type (2012-2017)
Figure United States Celiac Disease Sales Market Share by Type in 2016
Table United States Celiac Disease Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Celiac Disease Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Celiac Disease by Type (2012-2017)
Figure Revenue Market Share of Celiac Disease by Type in 2016
Table United States Celiac Disease Price (USD/Unit) by Types (2012-2017)
Figure United States Celiac Disease Sales Growth Rate by Type (2012-2017)
Table United States Celiac Disease Sales (K Units) by Application (2012-2017)
Table United States Celiac Disease Sales Market Share by Application (2012-2017)
Figure United States Celiac Disease Sales Market Share by Application (2012-2017)
Figure United States Celiac Disease Sales Market Share by Application in 2016
Table United States Celiac Disease Sales Growth Rate by Application (2012-2017)
Figure United States Celiac Disease Sales Growth Rate by Application (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Celiac Disease Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Celiac Disease Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche Celiac Disease Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Celiac Disease Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Celiac Disease Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Celiac Disease Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Celiac Disease Sales Growth Rate (2012-2017)
Figure Merck Celiac Disease Sales Market Share in United States (2012-2017)
Figure Merck Celiac Disease Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Celiac Disease Sales Growth Rate (2012-2017)
Figure Pfizer Celiac Disease Sales Market Share in United States (2012-2017)
Figure Pfizer Celiac Disease Revenue Market Share in United States (2012-2017)
Table ADMA Biologics Basic Information List
Table ADMA Biologics Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ADMA Biologics Celiac Disease Sales Growth Rate (2012-2017)
Figure ADMA Biologics Celiac Disease Sales Market Share in United States (2012-2017)
Figure ADMA Biologics Celiac Disease Revenue Market Share in United States (2012-2017)
Table Amgen Basic Information List
Table Amgen Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Celiac Disease Sales Growth Rate (2012-2017)
Figure Amgen Celiac Disease Sales Market Share in United States (2012-2017)
Figure Amgen Celiac Disease Revenue Market Share in United States (2012-2017)
Table Anthera Pharmaceuticals Basic Information List
Table Anthera Pharmaceuticals Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Anthera Pharmaceuticals Celiac Disease Sales Growth Rate (2012-2017)
Figure Anthera Pharmaceuticals Celiac Disease Sales Market Share in United States (2012-2017)
Figure Anthera Pharmaceuticals Celiac Disease Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Celiac Disease Sales Growth Rate (2012-2017)
Figure Bayer Celiac Disease Sales Market Share in United States (2012-2017)
Figure Bayer Celiac Disease Revenue Market Share in United States (2012-2017)
Table Biogen Basic Information List
Table Biogen Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biogen Celiac Disease Sales Growth Rate (2012-2017)
Figure Biogen Celiac Disease Sales Market Share in United States (2012-2017)
Figure Biogen Celiac Disease Revenue Market Share in United States (2012-2017)
Table BioLineRx Basic Information List
Table BioLineRx Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BioLineRx Celiac Disease Sales Growth Rate (2012-2017)
Figure BioLineRx Celiac Disease Sales Market Share in United States (2012-2017)
Figure BioLineRx Celiac Disease Revenue Market Share in United States (2012-2017)
Table Biotest Basic Information List
Table Bristol-Myers Squibb Basic Information List
Table Celgene Basic Information List
Table Takeda Pharmaceutical Basic Information List
Table Novartis Basic Information List
Table LFB Group Basic Information List
Table Kedrion Biopharma Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Celiac Disease
Figure Manufacturing Process Analysis of Celiac Disease
Figure Celiac Disease Industrial Chain Analysis
Table Raw Materials Sources of Celiac Disease Major Players/Suppliers in 2016
Table Major Buyers of Celiac Disease
Table Distributors/Traders List
Figure United States Celiac Disease Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Celiac Disease Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Celiac Disease Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Celiac Disease Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Celiac Disease Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Celiac Disease Sales Volume (K Units) Forecast by Type in 2022
Table United States Celiac Disease Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Celiac Disease Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Celiac Disease Sales Volume (K Units) Forecast by Application in 2022
Table United States Celiac Disease Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Celiac Disease Sales Volume Share Forecast by Region (2017-2022)
Figure United States Celiac Disease Sales Volume Share Forecast by Region (2017-2022)
Figure United States Celiac Disease Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources